VRTX Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: November 10, 2025

Report Source: 2025 3rd Quarter Report

Analyst's Ratings for Vertex Pharmaceuticals Inc (VRTX)

Based on 40 analysts giving stock ratings to Vertex Pharmaceuticals Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
25
Buy
39
Hold
33
Sell
0
Strong Sell
3
Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals Inc. Stock Analysis VRTX

United States Health Care Large Cap Report:
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The company is headquartered in Boston, Massachusetts and currently employs 6,100 full-time employees. The company has seven approved medicines: five that treat the underlying cause of cystic fibrosis (CF), one that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), and one that treats moderate-to-severe acute pain. Its pipeline includes clinical-stage programs in CF, SCD, beta thalassemia, acute and peripheral neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy and other autoimmune renal diseases and cytopenias, type 1 diabetes, myotonic dystrophy type 1, and autosomal dominant polycystic kidney disease. Its marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (elexacaftor/tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor), and KALYDECO (ivacaftor).
Read More

Vertex Pharmaceuticals Inc (VRTX) Chart

Vertex Pharmaceuticals Inc (VRTX) vs CBOE Volatility Index (VIX) Comparative Returns

Analysis of Vertex Pharmaceuticals Inc (VRTX) stock performance compared to the broader market (CBOE Volatility Index (VIX)) across multiple timeframes.

YTD Performance
  • Vertex Pharmace... (VRT...) 8.41%
  • CBOE Volatility Index (VIX) 7.42%
Vertex Pharmace... Outperformed CBOE Volatility Index (VIX) by 0.99%
1Y Performance
  • Vertex Pharmace... (VRT...) 6.25%
  • CBOE Volatility Index (VIX) -3.02%
Vertex Pharmace... Outperformed CBOE Volatility Index (VIX) by 9.27%
3Y Performance
  • Vertex Pharmace... (VRT...) 63.69%
  • CBOE Volatility Index (VIX) -19.46%
Vertex Pharmace... Outperformed CBOE Volatility Index (VIX) by 83.15%
5Y Performance
  • Vertex Pharmace... (VRT...) 129.68%
  • CBOE Volatility Index (VIX) -51.47%
Vertex Pharmace... Outperformed CBOE Volatility Index (VIX) by 181.15%

Key Statistics of Vertex Pharmaceuticals Inc (VRTX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$471.65$503.88

Today's Open

$471.65

Volume

2.92M

P/E Ratio (TTM)

-

52 Week Range

$362.50$519.68

Market Cap

119.22B

Avg. Volume

1.54M

Dividend Yield

-

Financial Metrics & Statements of Vertex Pharmaceuticals Inc (VRTX)

Super Investors Invested in Vertex Pharmaceuticals Inc (VRTX)

Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.

lock-image

Community-Curated Collections with Vertex Pharmaceuticals Inc (VRTX) ( With VRTX )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for Vertex Pharmaceuticals Inc (VRTX)

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.